![Ross Levine](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 1 M $ in data 30/06/2026
Ross L.
Levine is the founder of Ajax Therapeutics, Inc., founded in 2019, serving as Director since its founding.
Current jobs include Independent Director at Medicus Sciences Acquisition Corp.
since 2021; Member of the Supervisory Board at QIAGEN NV since 2016; Member of the Supervisory Board at QIAGEN GmbH; Professor at Weill Cornell Medical College since 2007; and Member of the Supervisory Board at QIAGEN Srl.
Former jobs include Chief of Molecular Cancer Medicine Services at Memorial Sloan Kettering Cancer Center from 2018 to 2022 and Scientific Advisor at eFFECTOR Therapeutics, Inc. Education includes a doctorate from The Johns Hopkins University School of Medicine and an undergraduate degree from Harvard College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
QIAGEN NV 0,01% | 23/01/2026 | 27.495 ( 0,01% ) | 1 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MEDICUS SCIENCES ACQUISITION CORP. | Direttore/Membro del Consiglio | 12/02/2021 |
QIAGEN GmbH
 QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Direttore/Membro del Consiglio | - |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2007 |
Qiagen SRL
 Qiagen SRL Medical SpecialtiesHealth Technology Provides molecular testing solutions | Direttore/Membro del Consiglio | - |
Ajax Therapeutics, Inc.
 Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Fondatore | 01/01/2019 |
| Società | Posizione | Fine |
|---|---|---|
| QIAGEN N.V. | Direttore/Membro del Consiglio | 23/01/2026 |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital | Corporate Officer/Principal | - |
| EFFECTOR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
QIAGEN NV
 QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital | Health Services |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Commercial Services |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Qiagen SRL
Qiagen SRL Medical SpecialtiesHealth Technology Provides molecular testing solutions | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ajax Therapeutics, Inc.
Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Commercial Services |
Medicus Sciences Acquisition Corp.
 Medicus Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
